Using RWE to Make Cost Decisions: A New Report
A recent article, published in JMCP (the Journal of Managed Care and Specialty Pharmacy), considers how RWE (real world… Read more
HEOR Feature
Featured
Voluntary Recall Guidance Released by FDA
The US Food and Drug Administration (FDA) issued its final guidance in April on initiating voluntary recalls for drugs, biologics, and medical… Read more
Pfizer and Headlands Health Partner to Increase Clinical Trial Diversity
Clinical trial participants are often far less diverse than the populations they represent, as clinical trial sites are often located in wealthier… Read more
Gilead Places Restrictions on 340B Drug Pricing for Hepatitis C Treatments
The drugmaker Gilead cut off 340B discounts for certain hepatitis C drugs to some hospitals if they do not provide claims data to their… Read more
The Latest Blogs from tHEORetically Speaking
- Boston Strategic Partners Supplier Spotlight
- Unlocking the Value of Real-World Data to Provide Real-World Care
- HealthLumen Supplier Spotlight
- Trends and challenges in the Value, Evidence, and Access landscape: an interview with David Sykes, Head of VEA, Fishawack Health
- Differentiate Your Product From the Competition: Give Healthcare Decision Makers the Information They Need
